Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heron Therapeutics Inc HRTX

Healthcare Biotechnology
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and... see more

Recent & Breaking News (NDAQ:HRTX)

Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain

PR Newswire May 1, 2019

Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management

PR Newswire April 1, 2019

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Benzinga.com  March 29, 2019

77% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study in Bunionectomy

PR Newswire March 11, 2019

Heron Therapeutics to Present at the 39th Annual Cowen Healthcare Conference

PR Newswire March 4, 2019

Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for IV Push

PR Newswire February 26, 2019

Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress

PR Newswire February 22, 2019

Heron Therapeutics to Present at the 8th Annual Leerink Partners Global Healthcare Conference

PR Newswire February 20, 2019

Heron Therapeutics Announces Retirement of Robert Rosen as President

PR Newswire February 5, 2019

New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis — Consolidated Revenues, Company Growth, and Expectations for 2019

GlobeNewswire January 30, 2019

40 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  January 18, 2019

Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises

PR Newswire January 7, 2019

90% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study

PR Newswire January 3, 2019

50 Biggest Movers From Monday

Benzinga.com  January 2, 2019

Heron Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

PR Newswire December 31, 2018

33 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  December 31, 2018

FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management

PR Newswire December 31, 2018

Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire November 27, 2018

Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference

PR Newswire November 20, 2018

U.S. Surgeon General Jerome Adams Discusses Opioid Alternatives and the Importance of Partnerships at Heron Therapeutics

PR Newswire November 12, 2018